Recurrent PSA-only prostate cancer following prostatectomy
Showing 1 - 25 of >10,000
Prostate Cancer Trial in New York (18F-Labeled Positron Emission Tomography (PET) Diagnostic Agent, PET MRI Imaging)
Not yet recruiting
- Prostate Cancer
- 18F-Labeled Positron Emission Tomography (PET) Diagnostic Agent
- PET MRI Imaging
-
New York, New YorkSmilow Comprehensive Prostate Cancer Center
Jan 9, 2023
Urologic Cancer, Biochemical Recurrence of Malignant Tumor of Prostate Trial in Freiburg (Pembrolizumab Injection [Keytruda],
Recruiting
- Urologic Cancer
- Biochemical Recurrence of Malignant Neoplasm of Prostate
- Pembrolizumab Injection [Keytruda]
- Salvage Radiation Therapy (SRT)
-
Freiburg, Baden-Württemberg, GermanyClinic of Urology, Medical Center - University of Freiburg
Nov 7, 2022
Stage I Prostate Cancer AJCC v8, Stage II Prostate Cancer AJCC v8, Stage IIA Prostate Cancer AJCC v8 Trial in Rochester (Food
Withdrawn
- Stage I Prostate Cancer AJCC v8
- +8 more
- Food Diary
- +2 more
-
Rochester, MinnesotaMayo Clinic
Jul 6, 2022
Recurrent Prostate Cancer After Surgery Trial in Rochester (Daily-adaptive Stereotactic Body Radiation Therapy)
Not yet recruiting
- Recurrent Prostate Cancer After Surgery
- Daily-adaptive Stereotactic Body Radiation Therapy
-
Rochester, New YorkWilmot Cancer Institute - Dept of Radiation Oncology
Jul 7, 2023
Prostate Specific Membrane Antigen PET/CT in Biopsy Free of PSA
Recruiting
- Prostatic Neoplasms
- Radical prostatectomy (RP)
-
Xi'an, Shaanxi, ChinaFirst Affiliated Hospital of Xi'an Jiaotong University
Jul 14, 2023
Validating 'Sexual Minorities and Prostate Cancer Scale' to Gold
Not yet recruiting
- Prostate Cancer
- +2 more
- (no location specified)
Mar 6, 2023
Prostate Cancer Trial in Providence (Cabazitaxel)
Terminated
- Prostate Cancer
-
Providence, Rhode IslandMiriam Hospital
Feb 23, 2022
Prostate Cancer Trial in Hefei (18F-PSMA-1007 PET/CT based on diagnostic model)
Not yet recruiting
- Prostate Cancer
- 18F-PSMA-1007 PET/CT based on diagnostic model
-
Hefei, Anhui, ChinaThe First Affiliated Hospital of USTC
Dec 6, 2022
Metastatic Castration Sensitive Prostate Cancer Trial in New York (Degarelix, Ipilimumab, Radical Prostatectomy)
Active, not recruiting
- Metastatic Castration Sensitive Prostate Cancer
- Degarelix
- +2 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Aug 4, 2022
Metastatic Prostate Adenocarcinoma, Oligometastatic Prostate Carcinoma, Prostate Adenocarcinoma Trial in Rochester
Active, not recruiting
- Metastatic Prostate Adenocarcinoma
- +6 more
- Intensity-Modulated Radiation Therapy
- +3 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 5, 2023
Prostate Adenocarcinoma, Recurrent Prostate Carcinoma Trial in Houston (Abiraterone Acetate, Bicalutamide, Degarelix)
Active, not recruiting
- Prostate Adenocarcinoma
- Recurrent Prostate Carcinoma
- Abiraterone Acetate
- +7 more
-
Houston, TexasM D Anderson Cancer Center
Dec 5, 2022
Prostatic Tumors, Prostate Tumors, Prostate Cancer Trial in New York (5-Azacitidine, all trans retinoic acid, Lupron)
Completed
- Prostatic Neoplasms
- +2 more
- 5-Azacitidine
- +2 more
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Aug 1, 2022
Prostate Adenocarcinoma, Stage IIB Prostate Cancer AJCC v8, Stage III Prostate Cancer AJCC v8 Trial in Scottsdale, Rochester
Active, not recruiting
- Prostate Adenocarcinoma
- +5 more
- Androgen Suppression
- +3 more
-
Scottsdale, Arizona
- +1 more
Jan 5, 2023
Recurrent Prostate Cancer Trial in Bern (Ultrahypofractionated salvage radiotherapy to a local recurrence after radical
Recruiting
- Recurrent Prostate Cancer
- Ultrahypofractionated salvage radiotherapy to a local recurrence after radical prostatectomy
- Androgen deprivation therapy
-
Bern, SwitzerlandInselgruppe AG, Inselspital
Mar 1, 2023
Prostate Cancer Trial in Winston-Salem (Robot-Assisted Radical Prostatectomy with MLG-COMPLETE Allograft Implantation,
Not yet recruiting
- Prostate Cancer
- Robot-Assisted Radical Prostatectomy with MLG-COMPLETE Allograft Implantation
- MLG-COMPLETE Allograft Implantation
-
Winston-Salem, North CarolinaWake Forest Baptist Comprehensive Cancer Center
Feb 23, 2023
PET-MR-PSA Prostate Cancer Recidive Study
Active, not recruiting
- Prostate Cancer Recurrent
-
Trondheim, NorwaySt Olavs Hospital, PET center
Mar 1, 2022
Prostate Cancer, Erectile Dysfunction Following Radical Prostatectomy Trial in Miami (BioDFence G3 Placental Tissue Membrane,
Not yet recruiting
- Prostate Cancer
- Erectile Dysfunction Following Radical Prostatectomy
- BioDFence G3 Placental Tissue Membrane
- Robot-Assisted Radical Prostatectomy
-
Miami, FloridaUniversity of Miami
Apr 24, 2023
Pain Management, Opioid Use, Prostate Cancer Trial in Winston-Salem (Oxycodone, Acetaminophen, Ketamine)
Not yet recruiting
- Pain Management
- +2 more
- Oxycodone
- +3 more
-
Winston-Salem, North CarolinaAtrium Health Wake Forest Baptist Comprehensive Cancer Center
Feb 2, 2023
Prostate Cancer Adenocarcinoma, Erectile Dysfunction Following Radical Prostatectomy Trial (using Indocyanine Green,
Not yet recruiting
- Prostate Cancer Adenocarcinoma
- Erectile Dysfunction Following Radical Prostatectomy
- using Indocyanine Green
- Nerve-sparing robot-assisted laparoscopic radical prostatectomy
- (no location specified)
Jul 21, 2023
Biochemically Recurrent Prostate Carcinoma, Prostate Adenocarcinoma Trial in Atlanta (procedure, radiation, other, drug)
Not yet recruiting
- Biochemically Recurrent Prostate Carcinoma
- Prostate Adenocarcinoma
- Biospecimen Collection
- +6 more
-
Atlanta, GeorgiaEmory University Hospital/Winship Cancer Institute
Oct 25, 2023
Prostate Cancer Trial in Madison (pTVG-HP, Nivolumab, GM-CSF)
Active, not recruiting
- Prostate Cancer
- pTVG-HP
- +2 more
-
Madison, WisconsinUniversity of Wisconsin Carbone Cancer Center
Feb 7, 2022
Prostate Cancer Recurrent Trial in Vienna (Salvage lymph node dissection)
Active, not recruiting
- Prostate Cancer Recurrent
- Salvage lymph node dissection
-
Vienna, AustriaMedical University of Vienna
Apr 4, 2022